COVID‐19 Reinfection in Children With Cancer: Clinical Course and Risk Factors

While children with cancer are at risk of severe COVID-19, little is known about reinfection. Among infections (n = 2075) in children (≤ 21 years old, median age = 10 years old) receiving cancer-directed therapy and reported to the Pediatric Oncology COVID-19 case report, reinfection represented 6%. Children with subsequent infections did not have lower odds of hospitalization, intensive care unit admission, or changes to cancer-directed therapy. Odds of reinfection were higher among children with hematologic malignancies but did not vary with sociodemographics, disease status, comorbidities, or vaccination status. The disease course for reinfected children was not less severe than the first infection, emphasizing the importance of preventing reinfection.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-11-04
DOI
https://doi.org/10.1002/pbc.32126
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COVID‐19 Reinfection in Children With Cancer: Clinical Course and Risk Factors

Joshua Richman, Jennifer Levine, Ravi Bhatia, Isaac Martinez et al.
Pediatric Blood & Cancer
COVID-19 and healthcare impacts
article

COVID‐19 Reinfection in Children With Cancer: Clinical Course and Risk Factors

Joshua Richman, Jennifer Levine, Ravi Bhatia, Isaac Martinez, Julienne Brackett, Emily E. Johnston, Julie Wolfson, Chen Dai, Pietro Miozzo, Elizabeth Davis, Carla Schwalm, Catriona Mowbray, Josephine H. HaDuong, David S. Dickens, Alissa R. Kahn, Archana Sharma, Jeremy Z. Fields
article en

Abstract

While children with cancer are at risk of severe COVID-19, little is known about reinfection. Among infections (n = 2075) in children (≤ 21 years old, median age = 10 years old) receiving cancer-directed therapy and reported to the Pediatric Oncology COVID-19 case report, reinfection represented 6%. Children with subsequent infections did not have lower odds of hospitalization, intensive care unit admission, or changes to cancer-directed therapy. Odds of reinfection were higher among children with hematologic malignancies but did not vary with sociodemographics, disease status, comorbidities, or vaccination status. The disease course for reinfected children was not less severe than the first infection, emphasizing the importance of preventing reinfection.

Pediatric Blood & CancerVol. 73(1)
Rutgers, The State University of New Jersey (US), University of Iowa (US), Boston Medical Center (US), Boston Children's Hospital (US), Children's Hospital of Orange County (US), Bronson Methodist Hospital (US), University of Alabama at Birmingham (US), Massachusetts General Hospital (US), Center for Cancer and Blood Disorders (US), Dana-Farber Cancer Institute (US), St. Joseph’s University Medical Center (US), Texas Children's Hospital (US), Saint Joseph's University (US)
Concern Foundation, University of Minnesota, State University of New York, Cleveland Clinic, University of Washington, Johns Hopkins University, University of North Carolina at Chapel Hill, SUNY Downstate Medical Center
Openalex Percentile: Top 56%
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.